XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -347.60% | -242.14% | 83.87% | -3.58% | -109.53% |
| Total Depreciation and Amortization | -11.48% | -2.73% | -0.68% | 0.68% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -181.81% | 141.22% | -197.67% | -35.60% | 1,482.46% |
| Change in Net Operating Assets | 4,655.21% | 105.65% | -350.81% | 156.46% | -29.34% |
| Cash from Operations | -438.91% | 28.89% | 10.88% | -2.75% | -11.89% |
| Capital Expenditure | 69.09% | -115.69% | 45.74% | -11.90% | 75.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.09% | -115.69% | 45.74% | -11.90% | 75.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -48.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | -3,721.91% | 342.19% |
| Foreign Exchange rate Adjustments | 197.34% | -139.01% | 984.86% | 106.93% | -679.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -291.60% | -88.27% | 82.37% | -60.71% | -92.92% |